Pulmonary heart disease, also known as cor pulmonale, is a condition characterized by the enlargement and dysfunction of the right side of the heart. This condition is typically a consequence of prolonged high blood pressure in the pulmonary arteries, which are responsible for carrying blood from the heart to the lungs. Chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and interstitial lung diseases are common contributors to the development of pulmonary heart disease. The increased resistance in the pulmonary circulation forces the right side of the heart to pump harder, leading to its enlargement and potential failure over time. Indications may involve difficulty breathing, tiredness, and edema in the legs. Timely diagnosis and management of the underlying respiratory condition are crucial in addressing and preventing the progression of pulmonary heart disease.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India